Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Clinical Obesity
|
January 12, 2023
Treating obesity as a chronic disease in Canada: We are not there yet
Sean Wharton
Canadian Journal of Diabetes
|
October 29, 2015
Current Perspectives on Long-term Obesity Pharmacotherapy
Sean Wharton
The New England Journal of Medicine
|
December 13, 2023
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply
Sean Wharton, Manige Konig
Postgraduate Medicine
|
January 24, 2023
Efficacy and safety of semaglutide for weight management: evidence from the STEP program
Anastassia Amaro, Danny Sugimoto, Sean Wharton
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
October 19, 2017
Weight loss medications in Canada - a new frontier or a repeat of past mistakes?
Sean Wharton, Jasmine Lee, Rebecca Ag Christensen
Obesity (Silver Spring, Md.)
|
September 23, 2022
Association between weight-loss history and weight loss achieved in clinical obesity management: Retrospective chart review
Jennifer L Kuk, Elham Kamran, Sean Wharton
Clinical Obesity
|
May 12, 2025
Ethnic differences in weight loss during a clinical obesity management program
Jennifer Linchee Kuk, Parmis Mirzadeh, Sean Wharton
Postgraduate Medicine
|
January 24, 2023
Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg
Janine V Kyrillos, Patrick M O'Neil, Sean Wharton
Clinical Obesity
|
March 21, 2021
An analysis of weight loss efforts and expectations in a Canadian Cohort: A retrospective medical chart review
Jennifer L Kuk, Maral Dehlehhosseinzadeh, Elham Kamran, et al.
Journal of Obesity
|
March 7, 2019
Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health
Jennifer L Kuk, Rebecca A G Christensen, Sean Wharton
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Clinical Obesity
|
January 12, 2023
Treating obesity as a chronic disease in Canada: We are not there yet
Sean Wharton
Canadian Journal of Diabetes
|
October 29, 2015
Current Perspectives on Long-term Obesity Pharmacotherapy
Sean Wharton
The New England Journal of Medicine
|
December 13, 2023
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply
Sean Wharton, Manige Konig
Postgraduate Medicine
|
January 24, 2023
Efficacy and safety of semaglutide for weight management: evidence from the STEP program
Anastassia Amaro, Danny Sugimoto, Sean Wharton
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
October 19, 2017
Weight loss medications in Canada - a new frontier or a repeat of past mistakes?
Sean Wharton, Jasmine Lee, Rebecca Ag Christensen
Obesity (Silver Spring, Md.)
|
September 23, 2022
Association between weight-loss history and weight loss achieved in clinical obesity management: Retrospective chart review
Jennifer L Kuk, Elham Kamran, Sean Wharton
Clinical Obesity
|
May 12, 2025
Ethnic differences in weight loss during a clinical obesity management program
Jennifer Linchee Kuk, Parmis Mirzadeh, Sean Wharton
Postgraduate Medicine
|
January 24, 2023
Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg
Janine V Kyrillos, Patrick M O'Neil, Sean Wharton
Clinical Obesity
|
March 21, 2021
An analysis of weight loss efforts and expectations in a Canadian Cohort: A retrospective medical chart review
Jennifer L Kuk, Maral Dehlehhosseinzadeh, Elham Kamran, et al.
Journal of Obesity
|
March 7, 2019
Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health
Jennifer L Kuk, Rebecca A G Christensen, Sean Wharton
Page
of 10